Princeton University’s Office of Technology Licensing is bringing on board Bradford Middlekauff as its first executive-in-residence. Middlekauff will join as a part-time consultant to help researchers and students with the commercialisation process.
Middlekauff was selected by the office for his knowledge of industry. He holds a law degree from Yale University and has worked for various pharmaceutical companies and biotechs, most recently he served as the chief legal officer at Kolltan Pharmaceuticals, a Yale spin-out, with previous positions including senior vice-president at biotech Medarex and associate at Cooley Goodward.
Middlekauff first had an opportunity to demonstrate his skillset to the university when he helped negotiate the university’s multi-million dollar, voluntary, contribution to the city budget.
Middlekauff and the office will be testing out different strategies and setting out priorities before formally committing to policies going forward.
Bradford Middlekauff said: “There are tremendously exciting, innovative and potentially life-saving technologies being developed at Princeton. There are lots of interesting scientific insights that arise in a laboratory setting that are not necessarily ripe for product development or commercialisation. We are very much looking to figure out what makes sense for the Princeton University entrepreneurial community.”
